Syros Pharmaceuticals, Inc. Quarterly Marketable Securities, Current in USD from Q4 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Syros Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2016 to Q1 2024.
  • Syros Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $24.8M, a 59.4% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $24.8M -$36.3M -59.4% Mar 31, 2024 10-Q 2024-05-14
Q2 2023 $28.5M +$1.32M +4.85% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $61M +$20.4M +50% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $34.8M -$3.23M -8.49% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $72.9M +$42.8M +142% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $27.2M +$6.11M +28.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $40.7M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $38.1M +$38.1M Dec 31, 2021 10-K 2023-03-02
Q3 2021 $30.2M Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $21.1M Jun 30, 2021 10-Q 2021-08-05
Q4 2020 $0 -$50M -100% Dec 31, 2020 10-K 2022-03-15
Q1 2020 $5M -$48.7M -90.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $50M +$182K +0.37% Dec 31, 2019 10-K 2021-03-04
Q3 2019 $74.8M +$5.07M +7.27% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $20M +$10M +100% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $53.7M +$26.3M +96.1% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $49.8M +$9.95M +25% Dec 31, 2018 10-K 2020-03-05
Q3 2018 $69.7M +$29.9M +75.1% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $9.98M -$2.01M -16.8% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $27.4M +$4.91M +21.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $39.8M +$14.8M +59.3% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $39.8M Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $12M Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $22.5M Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $25M Dec 31, 2016 10-K 2018-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.